Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

416 ARTÍCULOS , VIENDO DEL 91 AL 105

Therapeutic gardens as a design approach for optimising the healing environment of patients with Alzheimer's disease and other dementias: A narrative review

Uwajeh PC, Iyendo TO, Polay M.

Explore (NY). 2019 Sep-Oct;15(5):352-362. doi: 10.1016/j.explore.2019.05.002. Epub 2019 May 28.

Cognitive Assessment of Alzheimer's Disease and Dementias in Clinical Practice: Pragmatics of Brief Instruments and Neuropsychological Evaluation

Shaughnessy L, Sheard S, Goldfarb D, Atri A.

J Clin Psychiatry. 2019 Jun 25;80(4):MS18002BR2C. doi: 10.4088/JCP.MS18002BR2C.

"All is not lost"-Rethinking the nature of memory and the self in dementia

Strikwerda-Brown C, Grilli MD, Andrews-Hanna J, Irish M.

Ageing Res Rev. 2019 Sep;54:100932. doi: 10.1016/j.arr.2019.100932. Epub 2019 Jun 22.

How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years

Epelbaum S, Paquet C, Hugon J, Dumurgier J, Wallon D, Hannequin D, Jonveaux T, Besozzi A, Pouponneau S, Hommet C, Blanc F, Berly L, Julian A, Paccalin M, Pasquier F, Bellet J, Boutoleau-Bretonniere C, Charriau T, Rouaud O, Madec O, Mouton A, David R, Bekadar S, Fabre R, Liegey E, Deberdt W, Robert P, Dubois B.

BMJ Open. 2019 Jun 24;9(6):e029663. doi: 10.1136/bmjopen-2019-029663.

A systematic literature review of the effect of insulin sensitizers on the cognitive symptoms of Alzheimer's Disease in transgenic mice

Craig A, Parvez F, Issberner J.

Behav Brain Res. 2019 Oct 17;372:112015. doi: 10.1016/j.bbr.2019.112015. Epub 2019 Jun 27.

Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders

El-Hayek YH, Wiley RE, Khoury CP, Daya RP, Ballard C, Evans AR, Karran M, Molinuevo JL, Norton M, Atri A.

J Alzheimers Dis. 2019;70(2):323-341. doi: 10.3233/JAD-190426.

Effects of physical activity and exercise on the cognitive function of patients with Alzheimer disease: a meta-analysis

Jia RX, Liang JH, Xu Y, Wang YQ.

BMC Geriatr. 2019 Jul 2;19(1):181. doi: 10.1186/s12877-019-1175-2.

Dual-phase 18F-FP-CIT PET in corticobasal syndrome underlying AD pathology

Yoon JH, Ahn YS.

Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2208-2209. doi: 10.1007/s00259-019-04376-7. Epub 2019 Jul 4.

[Artificial Intelligence for Diagnostic Support of Neuroimage]

Shiino A.

Brain Nerve. 2019 Jul;71(7):733-748. doi: 10.11477/mf.1416201345.

Effects of vitamin D supplementation on cognitive function and blood Aβ-related biomarkers in older adults with Alzheimer's disease: a randomised, double-blind, placebo-controlled trial

Jia J, Hu J, Huo X, Miao R, Zhang Y, Ma F.

J Neurol Neurosurg Psychiatry. 2019 Dec;90(12):1347-1352. doi: 10.1136/jnnp-2018-320199. Epub 2019 Jul 11.

[Understanding the suffering of the elderly]

Thomas P, Chandès G, Hazif-Thomas C.

Soins Gerontol. 2019 Jul-Aug;24(138):28-31. doi: 10.1016/j.sger.2019.04.011.

Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [(18)F]MK6240 in human subjects

Guehl NJ, Wooten DW, Yokell DL, Moon SH, Dhaynaut M, Katz S, Moody KA, Gharagouzloo C, Kas A, Johnson KA, El Fakhri G, Normandin MD.

Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2099-2111. doi: 10.1007/s00259-019-04419-z. Epub 2019 Jul 22.

A Snapshot on the Current Status of Alzheimer's Disease, Treatment Perspectives, in-Vitro and in-Vivo Research Studies and Future Opportunities

Tezel G, Timur SS, Bozkurt İ, Türkoğlu ÖF, Eroğlu İ, Nemutlu E, Öner L, Eroğlu H.

Chem Pharm Bull (Tokyo). 2019 Oct 1;67(10):1030-1041. doi: 10.1248/cpb.c19-00511. Epub 2019 Jul 24.

Dance for People with Alzheimer's Disease: A Systematic Review

Ruiz-Muelle A, López-Rodríguez MM.

Curr Alzheimer Res. 2019;16(10):919-933. doi: 10.2174/1567205016666190725151614.

Using joint models to disentangle intervention effect types and baseline confounding: an application within an intervention study in prodromal Alzheimer's disease with Fortasyn Connect

van Oudenhoven FM, Swinkels SHN, Hartmann T, Soininen H, van Hees AMJ, Rizopoulos D.

BMC Med Res Methodol. 2019 Jul 25;19(1):163. doi: 10.1186/s12874-019-0791-z.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias